Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] - 1 Apr 2014

Langsenlehner T, Thurner E-M, Renner W, Gerger A, Kapp K S, Langsenlehner U

Abstract excerpt

BACKGROUND AND PURPOSE: Vascular endothelial growth factor-A (VEGF-A), a key regulator of tumor-induced angiogenesis, is critical for tumor growth and metastasization. The goal of the present study was to evaluate the prognostic value of VEGF single nucleotide polymorphisms (SNPs) and haplotypes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Austria
Share to Disease-Free Survival
Share to Longitudinal Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Recurrence, Local

Share to Prevalence

Share to Prostatic Neoplasms

Share to Survival Rate

Share to Vascular Endothelial Growth Factor A

Source

Identifiers

PMID: 24435801
DOI: 10.1007/s00066-013-0503-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24435801-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy.PMID 24435801Read ↗

Impact of VEGF gene polymorphisms and haplotypes on radiation-induced late toxicity in prostate cancer patients.Semantic proximity Read ↗

The EGFR polymorphism rs884419 is associated with freedom from recurrence in patients with resected prostate cancer.Semantic proximity Read ↗

Genome-wide detection of allelic genetic variation to predict biochemical recurrence after radical prostatectomy among prostate cancer patients using an exome SNP chip.Semantic proximity Read ↗

Improved prediction of biochemical recurrence after radical prostatectomy by genetic polymorphisms.Semantic proximity Read ↗

Genetic predisposition to early recurrence in clinically localized prostate cancer.Semantic proximity Read ↗

Prognostic Value of Prostaglandin-endoperoxide Synthase 2 Polymorphisms in Prostate Cancer Recurrence after Radical Prostatectomy.Semantic proximity Read ↗

Association of HSD3B1 Genotype With Response to Androgen-Deprivation Therapy for Biochemical Recurrence After Radiotherapy for Localized Prostate Cancer.Semantic proximity Read ↗

The matrix metalloproteinase-7 polymorphism rs10895304 is associated with increased recurrence risk in patients with clinically localized prostate cancer.Semantic proximity Read ↗

Impact of DNA repair gene polymorphisms on the risk of biochemical recurrence after radiotherapy and overall survival in prostate cancer.Semantic proximity Read ↗

ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy.Semantic proximity Read ↗

Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy.Semantic proximity Read ↗

An MGMT Allelic Variant Can Affect Biochemical Relapse in Prostate Cancer Patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.